Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr 9;5(4):556-558.
doi: 10.1002/hep4.1685. eCollection 2021 Apr.

Developing New Therapies for Delta Hepatitis: The Race Is On

Genco Gençdal  1 , Cihan Yurdaydin
Affiliations
Editorial

Developing New Therapies for Delta Hepatitis: The Race Is On

Genco Gençdal et al. Hepatol Commun. .
No abstract available

PubMed Disclaimer

References

    1. Yurdaydin C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat 2010;17:749‐756. - PubMed
    1. Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, et al. Prevalence and clinical course of hepatitis delta infection in Greece: a 13‐year prospective study. J Hepatol 2013;59:949‐956. - PubMed
    1. Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C, et al. The global prevalence of hepatitis D virus infection: systemic review and meta‐analysis. J Hepatol 2020;73:523‐532. - PMC - PubMed
    1. Wranke A, Hardtke S, Heidrich B, Dalekos G, Yalçin K, Tabak F, et al. Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta. J Viral Hepat 2020;27:1359‐1368. - PubMed
    1. Yurdaydin C, Keskin O, Kalkan Ç, Karakaya F, Çalişkan A, Kabaçam G, et al. Interferon treatment duration in patients with chronic delta hepatitis and its effect on the natural course of the disease. J Infect Dis 2018;217:1184‐1192. - PubMed

Publication types

MeSH terms

LinkOut - more resources